Open AccessInternational consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors
Author(s) -
T. Danne,
S. Garg,
A.L. Peters,
J.B. Buse,
C. Mathieu,
J.H. Pettus,
C.M. Alexander,
T. Battelino,
F.J. Ampudia-Blasco,
B.W. Bode,
B. Cariou,
K.L. Close,
P. Dandona,
Savi Dutta,
E. Ferrannini,
S. Fourlanos,
G. Grunberger,
S.R. Heller,
R.R. Henry,
M.J. Kurian,
J.A. Kushner,
T. Oron,
C.G. Parkin,
T.R. Pieber,
H.W. Rodbard,
D. Schatz,
J.S. Skyler,
W.V. Tamborlane,
K. Yokote,
M. Phillip
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7d94-y162
Subject(s) - diabetic ketoacidosis , medicine , type 2 diabetes , canagliflozin , diabetes mellitus , ketoacidosis , endocrinology , type 1 diabetes